SlideShare a Scribd company logo
1 of 22
Reg’ authorities and social media “ There’s something happening here. And what it is ain’t exactly clear”, Buffalo Springfield, the great social media philosopher
Why do we needreg’s to rule? ,[object Object],[object Object]
FDA hearing questions (Nov 2009) ,[object Object],[object Object],[object Object],[object Object],[object Object]
FDA Part 15 ,[object Object]
FDA speakers ,[object Object],[object Object],[object Object]
FDA speakers ,[object Object],[object Object],[object Object]
FDA speakers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
FDA speakers ,[object Object],[object Object]
FDA speakers ,[object Object],[object Object],[object Object],[object Object]
FDA speakers ,[object Object],[object Object],[object Object],[object Object]
Day 2 – Adverse events ,[object Object]
Adverse events / side effects ,[object Object]
AEs / side effects ,[object Object],[object Object],[object Object]
AEs / Side effects ,[object Object],[object Object],[object Object]
AEs / side effects ,[object Object],[object Object],[object Object],[object Object],[object Object]
AEs - side effects ,[object Object],[object Object],[object Object],[object Object],[object Object]
AEs / side effects ,[object Object],[object Object],[object Object]
Next??? ,[object Object],[object Object]
BBBBlooooogs ,[object Object],[object Object]
Downside ,[object Object]
Europe ,[object Object],[object Object],[object Object]
eHealth Week 2010 - Barcelona ,[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

More from EURORDIS - Rare Diseases Europe

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...EURORDIS - Rare Diseases Europe
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseEURORDIS - Rare Diseases Europe
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgEURORDIS - Rare Diseases Europe
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyEURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...EURORDIS - Rare Diseases Europe
 
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...EURORDIS - Rare Diseases Europe
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" EURORDIS - Rare Diseases Europe
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"EURORDIS - Rare Diseases Europe
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...EURORDIS - Rare Diseases Europe
 

More from EURORDIS - Rare Diseases Europe (20)

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...
 
RareConnect.org Update 2016
RareConnect.org Update 2016RareConnect.org Update 2016
RareConnect.org Update 2016
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare disease
 
Living with TRAPS poll results
Living with TRAPS poll resultsLiving with TRAPS poll results
Living with TRAPS poll results
 
Pitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.orgPitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.org
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
 
Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.org
 
Surveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org ExperienceSurveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org Experience
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients Globally
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...
 
Conference 3 "Outcomes of 15 National Conferences, "
Conference 3   "Outcomes of 15 National Conferences, "Conference 3   "Outcomes of 15 National Conferences, "
Conference 3 "Outcomes of 15 National Conferences, "
 
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...
 

FDA Social Media Hearing Part 15 Summary

  • 1. Reg’ authorities and social media “ There’s something happening here. And what it is ain’t exactly clear”, Buffalo Springfield, the great social media philosopher
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.

Editor's Notes

  1. Although the agency believes that many issues can be addressed through existing FDA regulations, special characteristics of Web 2.0 and other emerging technologies may require the agency to provide additional guidance to the industry on how the regulations should be applied.
  2. Part 15 – FDA asks questions of the general public and listens to the answers, and asks questions if they want. They will then use this plus any other testimony sent in to try to form public policy if not law.
  3. John Kamp (4As and the Coalition for Healthcare Communication) pointed out that the Michele Sharp (Eli Lilly) pointed out that Tony Blank (Boston Scientific and AdvaMed)
  4. RohitBhargava (Ogilvy 360 Digital Influence) offered a way to determine Jeff Francer (PhRMA) called for , FDA panelists got nervous, as they feared the agency logo would be co-opted and construed as an implied endorsement. John Mack (Pharma Marketing News) shared that , (obvious, but must be said),
  5. ArnieFreide argued that the Diana Zuckerman (National Research Center for Women & Families) commented that Robert Winder (VuMedia) made the point that (or non-clear authorship) Wayne Gattinella (WebMD) discussed how Tiffany Mura (Consensus Interactive) called for Craig Audet (sanofi-aventis) shared that the
  6. Mark Gaydos (s-ab, representing the Social Media Working Group - AZ, s-a, BMS, Millennium, Amgen). David Zinman (Yahoo!) commented that the (for example, I now have a Yahoo page that allows boxes to open up and expand on subjects related to where I am on the page
  7. Philomena McArthur and Liz Forminard (J&J) discussed Mark Bard (Manhattan Research), twice as many docs as pts! Stan Valencis (Acsys Interactive) pointed out that , Does your hospital have social media? John Mangano (comScore) shared that
  8. FardJohnmar (Envision Solutions) said, Lawrence Mickelberg (Euro RSCG 4D) said W. John Reeves (McCann Healthcare Worldwide) pointed out that Mary Anne Belliveau and Amy Cowan (Google) presented a
  9. Peter J. Pitts (Porter Novelli) said that , If regulated industry wants the FDA to be both regulator and colleague, then it’s not a leap of faith to imagine that the FDA would like industry to be proactive in its search for new ways to surface adverse events. , “In compliance” and “in the best interest of the public health” must not be mutually exclusive propositions.
  10. Tony Blank (Boston Scientific, AdvaMed) said that Kim Witczak (Private citizen) called for the Steve Findlay (Consumer’s Union) said that
  11. Chris Schroeder (HealthCentral) shared JefFFrancer (PhRMA) commented that RohitBhargava (Ogilvy 360 Digital Influence) made the point that
  12. Rick Wion (GolinHarris) shared that James Allen Heywood (PatientsLikeMe) asked, Diana Zuckerman (National Research Center for Women & Families) made the point that John Mack (Pharma Marketing News) shared research showing that only Paul Roellig (Bulletin News) suggested that
  13. Daniel Palestrant (Sermo) observed that Donna Wray (TGaS Advisors) Jonathan Richman (Dose of Digital) commented that Fabio Gratton (Ignite Health) shared data showing that Robert Grammatica (Rapp) asked,
  14. Jim Walker (Cadient Group) talked about Wendy Blackburn (Intouch Solutions) shared research demonstrating that Freda Lewis-Hall and Cliff Thumma (Pfizer) presented
  15. (not a redefinition of what an adverse event is)
  16. A big thanks to Peter J. Pitts (Porter Novelli) of DrugWonks.com, http://www.drugwonks.com/blog_post/blogger?date=2009-11&blog= He also has a list of related blogs that is out of this world.